Loading organizations...
Key people at Millipore.
Millipore, a key part of Merck KGaA's Life Science sector, provides a comprehensive portfolio for scientific research and biopharmaceutical manufacturing. Its offerings include advanced filtration, cell culture media, analytical chemistry solutions, and tools for drug development. Its technical expertise delivers precise, high-performance integrated solutions, ensuring quality and efficiency across life science workflows.
Millipore Corporation was founded in 1954 by Jack Bush. He capitalized on microporous membrane technology's declassification, developed by Lovell Corporation for U.S. Army Chemical Engineers to separate fluid components. Bush, son of scientist Vannevar Bush, recognized the commercial potential of these innovative filtering capabilities for science.
Customers comprise academic researchers, biotechnology firms, and pharmaceutical manufacturers globally. Millipore's vision aims to enable scientific discovery and accelerate therapeutic development, ultimately advancing global health. The company continuously innovates its offerings, addressing evolving demands in life science and healthcare to foster breakthroughs.
Millipore Corporation, founded in 1954, was a pioneering company in membrane filtration technology, specializing in microporous membranes for purifying fluids, detecting bacteria, and enabling sterile processing in industries like pharmaceuticals, brewing, and electronics.[1][2][3] It developed products such as the Durapore membrane for sterilizing injectables and systems for pure water production, serving pharmaceutical manufacturers, research labs, and water testing facilities by solving contamination and purification challenges.[2][3] The company grew through innovation and acquisitions, peaking with revenues like $9.96 million in 1966, before facing diversification struggles in the 1980s; it was acquired by Merck KGaA in 2010 for $7.2 billion and integrated into MilliporeSigma (EMD Millipore in the U.S.), now part of a global life sciences portfolio with over 300,000 products and €4.6 billion in 2014 revenues.[4][5][6]
Millipore was founded in 1954 by John (Jack) Bush in Watertown, Massachusetts, inspired by post-World War II needs for microporous membrane filters to detect bacteria in drinking water amid Europe's water pollution crisis.[1][2][3][5] Bush coined "millipore" for the membrane's numerous tiny pores; the technology stemmed from wartime developments refined by Caltech and produced via U.S. government contracts with Lovell Chemical.[2][3] Early traction came from water analysis, expanding to brewing (30% of 1966 sales for draft beer production) and pharmaceuticals by the 1960s, with revenue hitting $3.43 million in 1963 and a stock split in 1966.[1][2] Pivotal moments included 1967's Super-Q water system, 1968's automated filtration, 1969's China entry, and 1975's Worthington Biochemical acquisition for diagnostics; Bush retired in 1980.[1][3]
Millipore rode the post-WWII surge in water safety, biopharma sterilization, and industrial purification trends, capitalizing on government-backed membrane tech amid rising threats of water-borne diseases and pharma needs for pure inputs.[2][3] Timing aligned with 1960s-1970s booms in antibiotics fermentation, electronics (e.g., Japanese investments), and diagnostics, influencing ecosystems by standardizing sterile processing and enabling moon mission tech ties (1969 Apollo 11).[1][3] Market forces like global expansion and acquisitions strengthened its separations industry position, prefiguring life sciences consolidation; its 2010 Merck acquisition ($7.2B) and 2015 Sigma-Aldrich merger ($17B) amplified scale in lab supplies, accelerating scientific research and healthcare access worldwide.[4][5][6]
As MilliporeSigma under Merck KGaA, the legacy endures in a portfolio powering biopharma, research, and e-commerce-driven lab tools, with 19,000 employees and 72 sites.[6] Next steps likely involve AI-enhanced filtration, sustainable bioprocessing, and expanded digital platforms amid trends like personalized medicine and clean tech demands.[4] Its influence may evolve by dominating life sciences supply chains, fostering global R&D collaborations, and addressing purification bottlenecks in gene therapies—reinforcing its foundational role from 1954's modest filters to today's tech enabler.[5][7]
Key people at Millipore.
